2024-04-012025-03-312025-03-31false14634832ASHINGTON HEALTHCARE LIMITED2025-12-0247730falseiso4217:GBPxbrli:pure146348322024-03-31146348322025-03-31146348322024-04-012025-03-31146348322023-02-01146348322024-03-31146348322023-02-022024-03-3114634832bus:SmallEntities2024-04-012025-03-3114634832bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3114634832bus:FullAccounts2024-04-012025-03-3114634832bus:PrivateLimitedCompanyLtd2024-04-012025-03-3114634832core:WithinOneYear2025-03-3114634832core:AfterOneYear2025-03-3114634832core:WithinOneYear2024-03-3114634832core:AfterOneYear2024-03-3114634832core:ShareCapital2025-03-3114634832core:SharePremium2025-03-3114634832core:RevaluationReserve2025-03-3114634832core:OtherReservesSubtotal2025-03-3114634832core:RetainedEarningsAccumulatedLosses2025-03-3114634832core:ShareCapital2024-03-3114634832core:SharePremium2024-03-3114634832core:RevaluationReserve2024-03-3114634832core:OtherReservesSubtotal2024-03-3114634832core:RetainedEarningsAccumulatedLosses2024-03-3114634832core:LandBuildings2025-03-3114634832core:PlantMachinery2025-03-3114634832core:Vehicles2025-03-3114634832core:FurnitureFittings2025-03-3114634832core:OfficeEquipment2025-03-3114634832core:NetGoodwill2025-03-3114634832core:IntangibleAssetsOtherThanGoodwill2025-03-3114634832core:ListedExchangeTraded2025-03-3114634832core:UnlistedNon-exchangeTraded2025-03-3114634832core:LandBuildings2024-03-3114634832core:PlantMachinery2024-03-3114634832core:Vehicles2024-03-3114634832core:FurnitureFittings2024-03-3114634832core:OfficeEquipment2024-03-3114634832core:NetGoodwill2024-03-3114634832core:IntangibleAssetsOtherThanGoodwill2024-03-3114634832core:ListedExchangeTraded2024-03-3114634832core:UnlistedNon-exchangeTraded2024-03-3114634832core:LandBuildings2024-04-012025-03-3114634832core:PlantMachinery2024-04-012025-03-3114634832core:Vehicles2024-04-012025-03-3114634832core:FurnitureFittings2024-04-012025-03-3114634832core:OfficeEquipment2024-04-012025-03-3114634832core:NetGoodwill2024-04-012025-03-3114634832core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114634832core:ListedExchangeTraded2024-04-012025-03-3114634832core:UnlistedNon-exchangeTraded2024-04-012025-03-3114634832core:MoreThanFiveYears2024-04-012025-03-3114634832core:Non-currentFinancialInstruments2025-03-3114634832core:Non-currentFinancialInstruments2024-03-3114634832dpl:CostSales2024-04-012025-03-3114634832dpl:DistributionCosts2024-04-012025-03-3114634832core:LandBuildings2024-04-012025-03-3114634832core:PlantMachinery2024-04-012025-03-3114634832core:Vehicles2024-04-012025-03-3114634832core:FurnitureFittings2024-04-012025-03-3114634832core:OfficeEquipment2024-04-012025-03-3114634832dpl:AdministrativeExpenses2024-04-012025-03-3114634832core:NetGoodwill2024-04-012025-03-3114634832core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114634832dpl:GroupUndertakings2024-04-012025-03-3114634832dpl:ParticipatingInterests2024-04-012025-03-3114634832dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114634832core:ListedExchangeTraded2024-04-012025-03-3114634832dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114634832core:UnlistedNon-exchangeTraded2024-04-012025-03-3114634832dpl:CostSales2023-02-022024-03-3114634832dpl:DistributionCosts2023-02-022024-03-3114634832core:LandBuildings2023-02-022024-03-3114634832core:PlantMachinery2023-02-022024-03-3114634832core:Vehicles2023-02-022024-03-3114634832core:FurnitureFittings2023-02-022024-03-3114634832core:OfficeEquipment2023-02-022024-03-3114634832dpl:AdministrativeExpenses2023-02-022024-03-3114634832core:NetGoodwill2023-02-022024-03-3114634832core:IntangibleAssetsOtherThanGoodwill2023-02-022024-03-3114634832dpl:GroupUndertakings2023-02-022024-03-3114634832dpl:ParticipatingInterests2023-02-022024-03-3114634832dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-022024-03-3114634832core:ListedExchangeTraded2023-02-022024-03-3114634832dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-022024-03-3114634832core:UnlistedNon-exchangeTraded2023-02-022024-03-3114634832core:NetGoodwill2025-03-3114634832core:IntangibleAssetsOtherThanGoodwill2025-03-3114634832core:LandBuildings2025-03-3114634832core:PlantMachinery2025-03-3114634832core:Vehicles2025-03-3114634832core:FurnitureFittings2025-03-3114634832core:OfficeEquipment2025-03-3114634832core:AfterOneYear2025-03-3114634832core:WithinOneYear2025-03-3114634832core:ListedExchangeTraded2025-03-3114634832core:UnlistedNon-exchangeTraded2025-03-3114634832core:ShareCapital2025-03-3114634832core:SharePremium2025-03-3114634832core:RevaluationReserve2025-03-3114634832core:OtherReservesSubtotal2025-03-3114634832core:RetainedEarningsAccumulatedLosses2025-03-3114634832core:NetGoodwill2024-03-3114634832core:IntangibleAssetsOtherThanGoodwill2024-03-3114634832core:LandBuildings2024-03-3114634832core:PlantMachinery2024-03-3114634832core:Vehicles2024-03-3114634832core:FurnitureFittings2024-03-3114634832core:OfficeEquipment2024-03-3114634832core:AfterOneYear2024-03-3114634832core:WithinOneYear2024-03-3114634832core:ListedExchangeTraded2024-03-3114634832core:UnlistedNon-exchangeTraded2024-03-3114634832core:ShareCapital2024-03-3114634832core:SharePremium2024-03-3114634832core:RevaluationReserve2024-03-3114634832core:OtherReservesSubtotal2024-03-3114634832core:RetainedEarningsAccumulatedLosses2024-03-3114634832core:NetGoodwill2023-02-0114634832core:IntangibleAssetsOtherThanGoodwill2023-02-0114634832core:LandBuildings2023-02-0114634832core:PlantMachinery2023-02-0114634832core:Vehicles2023-02-0114634832core:FurnitureFittings2023-02-0114634832core:OfficeEquipment2023-02-0114634832core:AfterOneYear2023-02-0114634832core:WithinOneYear2023-02-0114634832core:ListedExchangeTraded2023-02-0114634832core:UnlistedNon-exchangeTraded2023-02-0114634832core:ShareCapital2023-02-0114634832core:SharePremium2023-02-0114634832core:RevaluationReserve2023-02-0114634832core:OtherReservesSubtotal2023-02-0114634832core:RetainedEarningsAccumulatedLosses2023-02-0114634832core:AfterOneYear2024-04-012025-03-3114634832core:WithinOneYear2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114634832core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114634832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114634832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114634832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114634832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114634832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114634832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114634832core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114634832core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114634832core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114634832bus:Director12024-04-012025-03-3114634832bus:Director22024-04-012025-03-3114634832bus:Director32024-04-012025-03-3114634832bus:Director42024-04-012025-03-3114634832core:FurnitureFittingsToolsEquipment2024-03-3114634832core:FurnitureFittingsToolsEquipment2024-04-012025-03-3114634832core:FurnitureFittingsToolsEquipment2025-03-31

ASHINGTON HEALTHCARE LIMITED

Registered Number
14634832
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

ASHINGTON HEALTHCARE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

BELL, Andrew David, Dr
CHOPRA, Rakesh
GILFILLAN, Lindsay John, Dr
KULLAR, Sukhpreet Singh

Registered Address

Lintonville Medical Group
Lintonville Terrace
Ashington
NE63 9UT

Registered Number

14634832 (England and Wales)
ASHINGTON HEALTHCARE LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3165,724184,909
Tangible assets416,87921,139
182,603206,048
Current assets
Stocks534,21947,826
Debtors6104,38091,495
Cash at bank and on hand12,7316,213
151,330145,534
Creditors amounts falling due within one year7(417,263)(392,761)
Net current assets (liabilities)(265,933)(247,227)
Total assets less current liabilities(83,330)(41,179)
Net assets(83,330)(41,179)
Capital and reserves
Called up share capital105105
Profit and loss account(83,435)(41,284)
Shareholders' funds(83,330)(41,179)
The financial statements were approved and authorised for issue by the Board of Directors on 2 December 2025, and are signed on its behalf by:
CHOPRA, Rakesh
Director
Registered Company No. 14634832
ASHINGTON HEALTHCARE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the Income Statement on a straight-line basis over the period of the lease.
Defined contribution pension plan
The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further obligation. Contributions to defined contribution plans are expensed in the period to which they relate. Amounts not paid are shown in other creditors in the Statement of Financial Position. The assets of the plan are held separately from the company in independently administered funds.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Amortisation
The goodwill is amortised over a period of 10 years on a straight line basis.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Fixtures and fittings15-
Vehicles25-
Office Equipment-3
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete). At each date of Statement of Financial Position, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Income Statement.
2.Average number of employees

20252024
Average number of employees during the year55
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 24191,847191,847
At 31 March 25191,847191,847
Amortisation and impairment
At 01 April 246,9386,938
Charge for year19,18519,185
At 31 March 2526,12326,123
Net book value
At 31 March 25165,724165,724
At 31 March 24184,909184,909
4.Tangible fixed assets

Land & buildings

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 24118,7501,7411,67722,169
Additions--4378561,293
At 31 March 25118,7502,1782,53323,462
Depreciation and impairment
At 01 April 24-7811091401,030
Charge for year-4,4922897725,553
At 31 March 25-5,2733989126,583
Net book value
At 31 March 25113,4771,7801,62116,879
At 31 March 24117,9691,6321,53721,139
5.Stocks

2025

2024

££
Other stocks34,21947,826
Total34,21947,826
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables90,78673,264
Other debtors7,47114,334
Prepayments and accrued income6,1233,897
Total104,38091,495
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables54,22480,615
Amounts owed to related parties314,375279,375
Taxation and social security1,1161,219
Other creditors43,94723,202
Accrued liabilities and deferred income3,6018,350
Total417,263392,761
8.Operating lease commitments
At 31 March 2025 the company had future minimum lease payments under non-cancellable operating leases of £48,000 (2024 - £60,000).
9.Parent-subsidiary relationships
The company is a wholly owned subsidiary of Ashington Central Limited, a company registered in England and Wales. The parent company is exempt from preparing group accounts.